Russell Investments Group, Ltd. - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 59 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q1 2022$209,000
-20.2%
214,898
-18.2%
0.00%
Q2 2021$262,000
-90.4%
262,680
-90.5%
0.00%
-100.0%
Q4 2020$2,741,000
-12.7%
2,756,000
-14.8%
0.01%
-28.6%
Q3 2020$3,139,000
-7.4%
3,236,000
-7.5%
0.01%
-12.5%
Q2 2020$3,389,000
+6.5%
3,500,000
+1.8%
0.01%0.0%
Q1 2020$3,182,000
+0.4%
3,439,000
+2.9%
0.01%
+33.3%
Q4 2019$3,168,000
+355.2%
3,343,000
+334.7%
0.01%
+500.0%
Q3 2019$696,000
-49.2%
769,000
-48.6%
0.00%
-66.7%
Q2 2019$1,369,000
-22.6%
1,497,000
-22.0%
0.00%0.0%
Q1 2019$1,769,000
+4.1%
1,919,000
+2.0%
0.00%
-25.0%
Q4 2018$1,699,000
-6.0%
1,882,000
-2.6%
0.00%
+33.3%
Q3 2018$1,807,000
-13.7%
1,932,000
-14.5%
0.00%
-25.0%
Q2 2018$2,095,000
-19.5%
2,260,000
-23.9%
0.00%0.0%
Q1 2018$2,603,000
-17.3%
2,970,000
-16.7%
0.00%
-20.0%
Q4 2017$3,146,000
+47.3%
3,565,000
+82.5%
0.01%
+25.0%
Q4 2016$2,136,0001,953,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2019
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders